Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer. Biomol Biomed [Internet]. 2024 Mar. 11 [cited 2024 May 15];24(2):346–359. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9489